Haematologica (Roma), 2016-03, Vol.101 (3), p.263-265
2016
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?
- Ist Teil von
- Haematologica (Roma), 2016-03, Vol.101 (3), p.263-265
- Ort / Verlag
- Italy
- Erscheinungsjahr
- 2016
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0390-6078eISSN: 1592-8721DOI: 10.3324/haematol.2015.139246Titel-ID: cdi_pubmed_primary_26928246
- Format
- –
- Schlagworte
- Agammaglobulinaemia Tyrosine Kinase, Alleles, Antineoplastic Agents - therapeutic use, Biomarkers, Tumor - genetics, Biomarkers, Tumor - metabolism, Bridged Bicyclo Compounds, Heterocyclic - therapeutic use, Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors, Class I Phosphatidylinositol 3-Kinases - genetics, Class I Phosphatidylinositol 3-Kinases - metabolism, Gene Expression, Gene Frequency, High-Throughput Nucleotide Sequencing, Humans, Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis, Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell - genetics, Leukemia, Lymphocytic, Chronic, B-Cell - pathology, Molecular Targeted Therapy, Prognosis, Protein-Tyrosine Kinases - antagonists & inhibitors, Protein-Tyrosine Kinases - genetics, Protein-Tyrosine Kinases - metabolism, Purines - therapeutic use, Pyrazoles - therapeutic use, Pyrimidines - therapeutic use, Quinazolinones - therapeutic use, Sulfonamides - therapeutic use, Tumor Suppressor Protein p53 - deficiency, Tumor Suppressor Protein p53 - genetics